The device is also intuitive and easy to use. Developer of medical devices designed to treat peripheral cardiovascular diseases. “It’s eye opening how the vessel responds. is a privately held company dedicated to developing simple, yet sophisticated, technologies that facilitate procedures used for. Brodmann in Reflow Medical’s press release. “We were impressed from the start with the acute luminal gain we were able to achieve,” commented Dr. SAN CLEMENTE, CA Reflow Medical, Inc., a California-based medical device company, introduces the Reflow Spex LP (Low Profile) 0.014 and 0.018-inch reinforced support catheters. Marianne Brodmann, MD, who is a professor and vascular specialist at the Medical University of Graz in Austria, serves as Principal Investigator for the study. The system is then recaptured and removed, without leaving anything behind.
The device consists of a retrievable nitinol stent system with radially expandable spikes-“spurs”-designed to create channels for increased uptake of antiproliferative limus-based drugs into the vessel wall.
The system allows for uniform expansion of the stent to maximize lumen diameter and may reduce acute vessel recoil and dissections, noted the company.Īccording to the company, the Temporary Spur stent system is engineered to fulfill an unmet clinical need in treating patients with critical limb ischemia.
Reflow medical trial#
announced it has completed enrollment in the DEEPER LIMUS clinical trial to evaluate the company’s Temporary Spur stent system, which is designed to treat long, diffuse, and severely calcified infrapopliteal disease. is a private company focused on the design and development of simple and effective technologies that empower the physician when accessing and treating discrete regions of the peripheral vasculature.
0 kommentar(er)
